2160. Performance of the Cepheid Rapid PCR Test for Patient Screening and Association with Efficacy of Suvratoxumab, A Novel Anti-Staphylococcus aureus Monoclonal Antibody, During the Phase 2 SAATELLITE study

BACKGROUND: Patients with lower airway Staphylococcus aureus (SA) colonization are at great risk (> 20%) of early-onset ventilator-associated pneumonia (VAP). Thus, a rapid test is required to identify patients at risk. Suvratoxumab (formerly MEDI4893) is a human monoclonal antibody that neutrali...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Ruzin, Alexey, Yu, Li, Barraud, Olivier, François, Bruno, Sánchez Garcia, Miguel, Eggimann, Philippe, Dequin, Pierre-Francois, Laterre, Pierre-François, Huberlant, Vincent, Viña, Lucia, Boulain, Thierry, Bretonnière, Cédric, Pugin, Jérôme, Trenado Álvarez, José, Catalina Hernandez Padilla, Ana, Vignaud, Julie, Vandamme, Drieke, Ali, Omar, Shoemaker, Kathryn, Colbert, Susan, Sellman, Bret R, McCarthy, Michael, Jafri, Hasan S, Esser, Mark T
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6810445/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1840
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires